WHITE PAPER
Hypothesis Generation Using NetraAI Reveals Genetic Drivers of Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers and can be divided into three histological subtypes with distinct presentation and prognoses: adenocarcinoma (ADC), squamous cell carcinoma (SCC), and large cell carcinoma (LCC).1 In addition to...
Drug and Placebo Response Modeling Using Assessment Data with NetraAI
Clinical scale patient reported outcomes are commonly used research tools that can be designed to provide quantitative or qualitative outputs. These assessments use objective scales and/or qualitative, open-ended responses that rely on self-reporting to collect...
Leveraging NetraAI to Identify Novel Insights for Pancreatic Cancer Patient Response to Therapy
Challenges with Pancreatic Cancer Pancreatic cancer is deemed the “silent killer” due to vague symptoms, late diagnosis, rapid progression, and poor response to therapy. As the 14th most common cancer but 7th leading cause of cancer-associated deaths, prolonging...